Saracatinib Fails to Reduce Alcohol-Seeking and Consumption in Mice and Human Participants

More effective treatments to reduce pathological alcohol drinking are needed. The glutamatergic system and the NMDA receptor (NMDAR), in particular, are implicated in behavioral and molecular consequences of chronic alcohol use, making the NMDAR a promising target for novel pharmacotherapeutics. Eth...

Descripción completa

Detalles Bibliográficos
Autores principales: Thompson, Summer L., Gianessi, Carol A., O'Malley, Stephanie S., Cavallo, Dana A., Shi, Julia M., Tetrault, Jeanette M., DeMartini, Kelly S., Gueorguieva, Ralitza, Pittman, Brian, Krystal, John H., Taylor, Jane R., Krishnan-Sarin, Suchitra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438169/
https://www.ncbi.nlm.nih.gov/pubmed/34531767
http://dx.doi.org/10.3389/fpsyt.2021.709559

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438169/
https://www.ncbi.nlm.nih.gov/pubmed/34531767
http://dx.doi.org/10.3389/fpsyt.2021.709559

Ejemplares similares